1	AstraZeneca	astrazeneca	NNP	p2=NNS	4	nsubj	4:A0=PAG
2	on	on	IN	_	1	prep	_
3	Monday	monday	NNP	_	2	pobj	_
4	rejected	reject	VBD	pb=reject.01	0	root	_
5	a	a	DT	p2=RB	13	det	_
6	"	"	``	_	13	punct	_
7	final	final	JJ	_	13	amod	_
8	"	"	''	_	13	punct	_
9	$	$	$	_	11	quantmod	_
10	119	0	CD	_	11	number	_
11	billion	#crd#	CD	_	13	nn	_
12	buyout	buyout	NN	p2=NNS	13	nn	_
13	offer	offer	NN	_	4	dobj	18:A0=PAG;4:A1=PPT
14	from	from	IN	_	13	prep	_
15	Pfizer	pfizer	NNP	_	14	pobj	_
16	,	,	,	_	13	punct	_
17	possibly	possibly	RB	_	18	advmod	18:AM-ADV
18	sinking	sink	VBG	pb=sink.01	13	partmod	_
19	a	a	DT	_	23	det	_
20	pharmaceutical	pharmaceutical	JJ	_	23	amod	_
21	mega	mega	JJ	p2=NN	23	hmod	_
22	-	-	HYPH	_	23	hyph	_
23	merger	merger	NN	_	18	dobj	27:A0=PAG;18:A1=PPT
24	that	that	WDT	p2=DT	27	nsubj	27:R-A0
25	could	could	MD	_	27	aux	27:AM-MOD
26	have	have	VB	_	27	aux	_
27	jeopardized	jeopardize	VBN	p2=JJ|pb=jeopardize.01	23	rcmod	_
28	jobs	job	NNS	_	27	dobj	27:A1=GOL
29	at	at	IN	_	28	prep	_
30	AZ	az	NNP	_	33	poss	_
31	's	's	POS	_	30	possessive	_
32	Maryland	maryland	NNP	_	33	nn	_
33	subsidiary	subsidiary	NN	_	29	pobj	_
34	,	,	,	_	33	punct	_
35	MedImmune	medimmune	NNP	_	33	appos	_
36	.	.	.	_	4	punct	_

1	Pfizer	pfizer	NNP	p2=NN	20	nsubj	6:A0=PAG;20:A0=PAG
2	,	,	,	_	1	punct	_
3	which	which	WDT	_	6	nsubj	6:R-A0
4	would	would	MD	_	6	aux	6:AM-MOD
5	have	have	VB	_	6	aux	_
6	created	create	VBN	pb=create.01	1	rcmod	_
7	the	the	DT	_	8	det	_
8	world	world	NN	_	12	poss	_
9	's	's	POS	_	8	possessive	_
10	largest	large	JJS	_	12	amod	_
11	drug	drug	NN	_	12	nn	_
12	company	company	NN	_	6	dobj	6:A1=PPT
13	through	through	IN	_	6	prep	6:AM-MNR
14	the	the	DT	_	15	det	_
15	deal	deal	NN	_	13	pobj	_
16	,	,	,	_	20	punct	_
17	on	on	IN	_	20	prep	20:AM-TMP
18	Sunday	sunday	NNP	_	19	nn	_
19	evening	evening	NN	_	17	pobj	_
20	increased	increase	VBD	pb=increase.01	0	root	_
21	its	its	PRP$	_	31	poss	_
22	earlier	early	JJR	p2=RBR	25	amod	_
23	$	$	$	_	25	quantmod	_
24	106	0	CD	_	25	number	_
25	billion	#crd#	CD	_	31	nn	_
26	cash	cash	NN	_	31	nn	_
27	-	-	HYPH	_	26	hyph	_
28	and	and	CC	_	26	cc	_
29	-	-	HYPH	_	30	hyph	_
30	stock	stock	NN	_	26	conj	_
31	bid	bid	NN	_	20	dobj	20:A1=PPT
32	.	.	.	_	20	punct	_

1	In	in	IN	_	9	prep	9:AM-LOC;17:AM-LOC
2	a	a	DT	_	3	det	_
3	statement	statement	NN	_	1	pobj	_
4	,	,	,	_	9	punct	_
5	AstraZeneca	astrazeneca	NNP	_	6	nn	_
6	Chairman	chairman	NNP	_	8	nn	_
7	Leif	leif	NNP	_	8	nn	_
8	Johansson	johansson	NNP	_	9	nsubj	9:A0=PAG;17:A0
9	called	call	VBD	pb=call.01	0	root	_
10	that	that	DT	p2=IN	12	det	_
11	new	new	JJ	_	12	amod	_
12	offer	offer	NN	_	9	dobj	9:A1=PPT
13	"	"	``	_	14	punct	_
14	inadequate	inadequate	JJ	_	9	oprd	9:A2=PRD
15	"	"	''	_	14	punct	_
16	and	and	CC	_	9	cc	_
17	said	say	VBD	pb=say.01	9	conj	_
18	it	it	PRP	_	20	nsubj	20:A0=PAG
19	would	would	MD	_	20	aux	20:AM-MOD
20	have	have	VB	pb=have.03	17	ccomp	17:A1=PPT
21	"	"	``	_	23	punct	_
22	serious	serious	JJ	_	23	amod	_
23	consequences	consequence	NNS	_	20	dobj	20:A1=PPT
24	for	for	IN	_	23	prep	_
25	the	the	DT	_	26	det	_
26	company	company	NN	_	24	pobj	_
27	,	,	,	_	26	punct	_
28	our	our	PRP$	_	29	poss	_
29	employees	employee	NNS	_	26	conj	_
30	and	and	CC	_	29	cc	_
31	the	the	DT	_	35	det	_
32	life	life	NN	_	34	hmod	_
33	-	-	HYPH	_	34	hyph	_
34	sciences	science	NNS	_	35	nn	_
35	sector	sector	NN	_	29	conj	_
36	in	in	IN	_	35	prep	_
37	the	the	DT	_	38	det	_
38	U.K.	u.k.	NNP	_	36	pobj	_
39	,	,	,	_	38	punct	_
40	Sweden	sweden	NNP	_	38	conj	_
41	and	and	CC	_	40	cc	_
42	the	the	DT	_	43	det	_
43	U.S.	u.s.	NNP	_	40	conj	_
44	"	"	``	p2=''	48	punct	_
45	Johansson	johansson	NNP	_	47	poss	_
46	's	's	POS	_	45	possessive	_
47	statement	statement	NN	_	48	nsubj	48:A0=PAG
48	underscores	underscore	VBZ	pb=underscore.01	20	advcl	_
49	the	the	DT	_	50	det	_
50	fears	fear	NNS	_	48	dobj	48:A1=PPT
51	of	of	IN	_	50	prep	_
52	job	job	NN	_	53	nn	_
53	losses	loss	NNS	_	51	pobj	54:A1=PPT
54	surrounding	surround	VBG	pb=surround.01	53	partmod	_
55	an	an	DT	_	59	det	_
56	AstraZeneca	astrazeneca	NNP	_	58	nn	_
57	/	/	SYM	_	58	punct	_
58	Pfizer	pfizer	NNP	_	59	nn	_
59	deal	deal	NN	_	54	dobj	54:A2=GOL
60	,	,	,	_	53	punct	_
61	including	include	VBG	_	53	prep	_
62	at	at	IN	_	61	prep	_
63	MedImmune	medimmune	NNP	_	62	pobj	_
64	,	,	,	_	63	punct	_
65	a	a	DT	_	70	det	_
66	cornerstone	cornerstone	NN	_	70	nn	_
67	Montgomery	montgomery	NNP	_	68	nn	_
68	County	county	NNP	_	70	nn	_
69	biotech	biotech	NN	p2=DT	70	nn	_
70	company	company	NN	_	63	appos	72:A0=PAG
71	now	now	RB	_	72	advmod	72:AM-TMP
72	serving	serve	VBG	pb=serve.01	70	partmod	_
73	as	as	IN	_	72	prep	72:A1=PPT
74	a	a	DT	_	77	det	_
75	biologics	biologics	NNS	p2=NN	77	nn	_
76	R&D	r&d	NN	p2=NNP	77	nn	_
77	center	center	NN	_	73	pobj	_
78	for	for	IN	_	77	prep	_
79	its	its	PRP$	_	81	poss	_
80	U.K.	u.k.	NNP	_	81	nn	_
81	parent	parent	NN	_	78	pobj	_
82	.	.	.	_	9	punct	_

1	Maryland	maryland	NNP	p2=NN	2	nn	_
2	lawmakers	lawmaker	NNS	_	3	nsubj	3:A0=PAG
3	sought	seek	VBD	pb=seek.01	0	root	_
4	guarantees	guarantee	NNS	_	3	dobj	3:A1=PPT
5	from	from	IN	_	4	prep	_
6	Pfizer	pfizer	NNP	_	5	pobj	_
7	that	that	IN	p2=WDT	12	complm	_
8	MedImmune	medimmune	NNP	_	12	nsubjpass	12:A1=DIR
9	would	would	MD	_	12	aux	12:AM-MOD
10	n't	not	RB	_	12	neg	12:AM-NEG
11	be	be	VB	_	12	auxpass	_
12	gutted	gut	VBN	pb=gut.01	4	ccomp	_
13	under	under	IN	_	12	prep	12:AM-LOC
14	the	the	DT	_	15	det	_
15	acquisition	acquisition	NN	_	13	pobj	_
16	.	.	.	_	3	punct	_

1	MedImmune	medimmune	NNP	p2=NN	6	nsubj	6:A0=PAG
2	,	,	,	_	6	punct	_
3	meanwhile	meanwhile	RB	_	6	advmod	6:AM-TMP
4	,	,	,	_	6	punct	_
5	had	have	VBD	_	6	aux	_
6	touted	tout	VBN	pb=tout.01	0	root	_
7	its	its	PRP$	_	8	poss	_
8	portfolio	portfolio	NN	_	6	dobj	6:A1=PPT
9	â€	â€	,	p2=NN	6	punct	_
10	"	"	``	p2=''	6	punct	_
11	especially	especially	RB	_	14	advmod	_
12	the	the	DT	_	14	det	_
13	immunotherapy	immunotherapy	JJ	p2=NN	14	amod	_
14	product	product	NN	_	20	advcl	_
15	MEDI4736	medi4736	NNP	p2=NN	14	appos	_
16	â€	â€	,	p2=NNP	6	punct	_
17	"	"	``	p2=''	19	punct	_
18	to	to	TO	_	19	aux	_
19	help	help	VB	pb=help.01	1	ccomp	_
20	make	make	VB	pb=make.02	19	xcomp	19:A1=PPT
21	the	the	DT	_	22	det	_
22	case	case	NN	_	20	dobj	20:A1=PRD
23	that	that	IN	p2=DT	27	complm	_
24	Pfizer	pfizer	NNP	_	26	poss	_
25	's	's	POS	_	24	possessive	_
26	bid	bid	NN	_	27	nsubj	27:A1=PPT
27	was	be	VBD	pb=be.01	20	ccomp	_
28	too	too	RB	_	29	advmod	_
29	low	low	JJ	_	27	acomp	27:A2=PRD
30	.	.	.	_	6	punct	_

1	The	the	DT	_	2	det	_
2	rejection	rejection	NN	_	3	nsubj	3:A0
3	leaves	leave	VBZ	p2=NNS|pb=leave.01	0	root	_
4	MedImmune	medimmune	NNP	_	3	dobj	3:A1=DIR
5	intact	intact	JJ	p2=RB	3	oprd	3:A2=PRD
6	,	,	,	_	3	punct	_
7	for	for	IN	_	3	prep	3:AM-TMP
8	now	now	RB	_	7	pcomp	_
9	.	.	.	_	3	punct	_

1	Since	since	IN	_	16	prep	16:AM-TMP
2	buying	buy	VBG	pb=buy.01	1	pcomp	_
3	the	the	DT	_	5	det	_
4	Maryland	maryland	NNP	p2=JJ	5	nn	_
5	company	company	NN	_	2	dobj	2:A1=PPT
6	for	for	IN	_	2	prep	2:A3=VSP
7	$	$	$	_	9	quantmod	_
8	15.6	0	CD	_	9	number	_
9	billion	#crd#	CD	_	6	pobj	_
10	in	in	IN	_	9	prep	_
11	2007	0	CD	_	10	pobj	_
12	,	,	,	_	16	punct	_
13	AstraZeneca	astrazeneca	NNP	_	16	nsubj	16:A0=PAG;19:A0=PAG
14	has	have	VBZ	_	16	aux	_
15	fundamentally	fundamentally	RB	_	16	advmod	16:AM-MNR
16	reshaped	reshape	VBN	p2=JJ|pb=reshape.01	0	root	_
17	MedImmune	medimmune	NNP	_	16	dobj	16:A1=PPT
18	while	while	IN	_	19	mark	_
19	preserving	preserve	VBG	pb=preserve.01	16	advcl	16:AM-TMP
20	it	it	PRP	_	19	dobj	19:A1=PPT
21	as	as	IN	_	19	prep	19:AM-LOC
22	a	a	DT	_	25	det	_
23	major	major	JJ	_	25	amod	_
24	job	job	NN	_	25	nn	_
25	center	center	NN	_	21	pobj	_
26	.	.	.	_	16	punct	_

1	That	that	DT	_	2	nsubj	2:A1=PPT
2	stands	stand	VBZ	p2=NNS|pb=stand.01	0	root	_
3	in	in	IN	p2=RP	2	prep	2:A2=LOC
4	sharp	sharp	JJ	_	5	amod	_
5	contrast	contrast	NN	_	3	pobj	_
6	with	with	IN	_	5	prep	_
7	GlaxoSmithKline	glaxosmithkline	NNP	_	9	poss	_
8	's	's	POS	_	7	possessive	_
9	treatment	treatment	NN	_	6	pobj	_
10	of	of	IN	_	9	prep	_
11	Rockville	rockville	NNP	_	13	hmod	_
12	-	-	HYPH	_	13	hyph	_
13	based	base	VBN	_	16	amod	_
14	Human	human	NNP	p2=NN	16	nn	_
15	Genome	genome	NNP	_	16	nn	_
16	Sciences	science	NNPS	_	10	pobj	_
17	.	.	.	_	2	punct	_

1	Bill	bill	NNP	p2=NN	2	nn	_
2	Flook	flook	NNP	_	3	nsubj	3:A0=PAG
3	covers	cover	VBZ	pb=cover.01	0	root	_
4	technology	technology	NN	_	3	dobj	3:A1=PPT
5	,	,	,	_	4	punct	_
6	biotech	biotech	NN	p2=NNS	4	conj	_
7	and	and	CC	_	6	cc	_
8	venture	venture	NN	_	9	nn	_
9	capital	capital	NN	_	6	conj	_
10	.	.	.	_	3	punct	_

1	If	if	IN	_	4	mark	_
2	you	you	PRP	_	4	nsubj	4:A0=PAG;5:A0=PAG
3	are	be	VBP	_	4	aux	_
4	commenting	comment	VBG	pb=comment.01	15	advcl	15:AM-ADV
5	using	use	VBG	pb=use.01	4	xcomp	4:A1=PPT
6	a	a	DT	_	8	det	_
7	Facebook	facebook	NNP	p2=NN	8	nn	_
8	account	account	NN	_	5	dobj	5:A1=PPT
9	,	,	,	_	15	punct	_
10	your	your	PRP$	_	12	poss	_
11	profile	profile	NN	p2=JJ	12	nn	_
12	information	information	NN	_	15	nsubjpass	15:A1=PPT
13	may	may	MD	_	15	aux	15:AM-MOD
14	be	be	VB	_	15	auxpass	_
15	displayed	display	VBN	pb=display.01	0	root	_
16	with	with	IN	_	15	prep	15:A2=LOC
17	your	your	PRP$	_	18	poss	_
18	comment	comment	NN	_	16	pobj	19:A0=PAG
19	depending	depend	VBG	pb=depend.01	18	partmod	_
20	on	on	IN	_	19	prep	19:A1=PPT
21	your	your	PRP$	_	23	poss	_
22	privacy	privacy	NN	_	23	nn	_
23	settings	setting	NNS	_	20	pobj	_
24	.	.	.	_	15	punct	_

1	By	by	IN	_	16	prep	16:AM-MNR
2	leaving	leave	VBG	pb=leave.01	1	pcomp	_
3	the	the	DT	_	5	det	_
4	'	'	``	p2=''	5	punct	_
5	Post	post	NNP	p2=JJ	2	dobj	2:A1=DIR
6	to	to	IN	p2=TO	2	prep	2:A2=PRD
7	Facebook	facebook	NNP	_	9	poss	_
8	'	'	POS	p2=''	7	possessive	_
9	box	box	NN	_	6	pobj	10:A1=PPT
10	selected	select	VBD	p2=VBN|pb=select.01	9	partmod	_
11	,	,	,	_	16	punct	_
12	your	your	PRP$	_	13	poss	_
13	comment	comment	NN	_	16	nsubjpass	16:A1=PRD
14	will	will	MD	_	16	aux	16:AM-MOD
15	be	be	VB	_	16	auxpass	_
16	published	publish	VBN	pb=publish.01	0	root	_
17	to	to	IN	_	16	prep	16:AM-GOL
18	your	your	PRP$	_	20	poss	_
19	Facebook	facebook	NNP	p2=NN	20	nn	_
20	profile	profile	NN	p2=VB	17	pobj	_
21	in	in	IN	_	16	prep	16:AM-LOC
22	addition	addition	NN	_	21	pobj	_
23	to	to	IN	_	22	prep	_
24	the	the	DT	_	25	det	_
25	space	space	NN	_	23	pobj	_
26	below	below	RB	_	25	advmod	_
27	.	.	.	_	16	punct	_

1	Stay	stay	VB	pb=stay.01	0	root	_
2	on	on	IN	_	1	prep	1:A3
3	top	top	NN	_	2	pobj	_
4	of	of	IN	_	3	prep	_
5	the	the	DT	_	8	det	_
6	latest	late	JJS	_	8	amod	_
7	tech	tech	NN	_	8	nn	_
8	news	news	NN	_	4	pobj	_
9	from	from	IN	_	8	prep	_
10	Washington	washington	NNP	_	9	pobj	_
11	and	and	CC	_	9	cc	_
12	beyond	beyond	IN	p2=RB	9	conj	_
13	.	.	.	_	1	punct	_

